CONTEMPORARY APPROACH TO THE CORRECTION OF COGNITIVE DISORDERS IN PATIENTS WITH VASCULAR COMORBIDITY

CONTEMPORARY APPROACH TO THE CORRECTION OF COGNITIVE DISORDERS IN PATIENTS WITH VASCULAR COMORBIDITY

Show other versions (1)

Various aspects of the therapy of patients with cognitive impairments and vascular comorbidity, including cerebral stroke and chronic brain ischemia associated with cardiac and endocrine diseases are discussed. Influence of vascular cognitive and psycho-emotional disorders on the social and everyday...

Full description

Bibliographic Details
Main Authors:	S. A. Rumianceva, V. A. Stupin, V. V. Afanas'ev, E. V. Silina, S. P. Svishсheva, E. N. Kabaeva, L. A. Cukurova
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	cognitive disorders vascular comorbidity stroke chronic ischemia vinpocetine
Online Access:	https://www.rpcardio.online/jour/article/view/279

Similar Items

CONTEMPORARY APPROACH TO THE CORRECTION OF COGNITIVE DISORDERS IN PATIENTS WITH VASCULAR COMORBIDITY
by: S. A. Rumianceva, et al.
Published: (2015-09-01)

PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY
by: S. A. Rumyantseva, et al.
Published: (2015-09-01)

Chronic cerebrovascular diseases: use of vinpocetine in neurological practice (Round Table proceedings)
by: V. A. Parfenov, et al.
Published: (2018-12-01)

CHRONIC BRAIN ISCHEMIA. CURRENT STATE OF THE PROBLEM
by: E. A. ANTIPENKO, et al.
Published: (2016-12-01)

NEUROLOGICAL DISORDERS IN PATIENTS WITH HYPERTENSION AND THEIR CORRECTION
by: N. V. Vakhnina, et al.
Published: (2016-12-01)

Current approaches to the diagnosis, prevention, and therapy of cognitive impairments in vascular encephalopathy
by: V.Yu. Lobzin, et al.
Published: (2014-06-01)

Study of the effects of vinpocetine on indicators of acidalkaline state followıng the ischemic brain damage
by: Larisa M. Makarova, et al.
Published: (2023-04-01)

PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY
by: S. A. Rumyantseva, et al.
Published: (2015-09-01)

INITIAL FORMS OF CEREBROVASCULAR INSUFFICIENCY: DIFFERENT APPROACHES TO THERAPY (ON THE RESULTS OF THE CLINICAL AND EPIDEMIOLOGICAL PROGRAM «PROFILE»)
by: N. N. Koberskaya, et al.
Published: (2018-02-01)

Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions
by: V. A. Golovacheva, et al.
Published: (2021-04-01)

Current approaches to therapy for chronic forms of cerebrovascular diseases
by: Maksim Alekseyevich Domashenko, et al.
Published: (2012-03-01)

Investigation of the protective and treatment effects of vinpocetine in myocardial infarctional with isoprotenol in rats
by: Taner Guven, et al.
Published: (2017-12-01)

VASCULAR COMORBIDITY: GENERAL APPROACHES TO PREVENTION AND TREATMENT
by: R. G. Oganov
Published: (2015-09-01)

VASCULAR COMORBIDITY: GENERAL APPROACHES TO PREVENTION AND TREATMENT
by: R. G. Oganov
Published: (2015-09-01)

Study of vinpocetine intranasal dosage form consistence properties
by: N. A. Nagornaya, et al.
Published: (2014-10-01)

The role of comorbidity in the development of Long-COVID
by: T.V. Chernii, et al.
Published: (2022-10-01)

SURVIVAL ANALYSIS AND SPATIAL-FREQUENCY DISTRIBUTION OF EEG-INDICES IN RATS’ GLOBAL CEREBRAL ISCHEMIA
by: E. V. GANTSGORN, et al.
Published: (2017-06-01)

Chronic cerebral circulatory disorders: possibilities of enhancing the efficiency of therapy
by: P. R. Kamchatnov, et al.
Published: (2017-11-01)

Assessment of the prevalence of nootropic drugs by elderly patients in geriatric practice
by: Emilia Główczewska-Siedlecka, et al.
Published: (2017-08-01)

Assessment of the prevalence of nootropic drugs by elderly patients in geriatric practice
by: Emilia Główczewska-Siedlecka, et al.
Published: (2017-08-01)

Editorial: Serum uric acid, vascular aging, and endocrine comorbidities
by: Yijun Hu, et al.
Published: (2023-09-01)

Specific features of free radical processes in comorbid patients with acute stroke and transient ischemic attack
by: A.S. Orlova, et al.
Published: (2014-10-01)

UV SPECTROPHOTOMETRY APPLICATION FOR QUANTITATIVE DETERMINATION OF VINPOCETINE IN DRUG FORMULATIONS
by: J. V. Monaykina, et al.
Published: (2014-12-01)

Current approaches to preventing and treating chronic cerebral circulatory disorder
by: Marina Yuryevna Maksimova, et al.
Published: (2012-12-01)

Vinpocetine Protects Against Cerebral Ischemia-Reperfusion Injury by Targeting Astrocytic Connexin43 via the PI3K/AKT Signaling Pathway
by: Mingming Zhao, et al.
Published: (2020-04-01)

PEG- 4000 increases solubility and dissolution rate of vinpocetin in solid dispersion system
by: Yulia A. Polkovnikova, et al.
Published: (2022-06-01)

Neuroprotective Effect of Vinpocetine against Lead Acetate-Instigated Neurotoxicity in Rats by Evaluation Tumor Necrosis Factor-Alpha, Interleukin-1Beta and Interleukin-10
by: Manal Abdulkhaliq Ibrahim, et al.
Published: (2022-12-01)

Chemoreactom analysis of cytidyldiphosphocholine indicates synergistic combinations of neuroprotective agents
by: I. Yu. Torshin, et al.
Published: (2021-04-01)

Impact of Retinopathy and Systemic Vascular Comorbidities on All-Cause Mortality
by: Zhuoting Zhu, et al.
Published: (2021-11-01)

Comparative study of the specific activity of soft application drugs with vinpocetine
by: V. V. Hladyshev, et al.
Published: (2022-12-01)

Vinpocetine Ameliorates Metabolic-Syndrome-Associated Bladder Overactivity in Fructose-Fed Rats by Restoring Succinate-Modulated cAMP Levels and Exerting Anti-Inflammatory Effects in the Bladder Detrusor Muscle
by: Wei-Chia Lee, et al.
Published: (2022-10-01)

Beneficial effects of certain phosphodiesterase inhibitors on diabetes mellitus in rats
by: Mostafa El Sayed El Sayed, et al.
Published: (2014-12-01)

Anti-inflammatory effects of vinpocetine in LPS-stimulated microglia via activation of AMPK
by: QIN ZHOU, et al.
Published: (2020-11-01)

Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL/6J mice
by: Yuri A. Blednov, et al.
Published: (2014-05-01)

Gender features of comorbidity in patients with coronary artery disease
by: A.N. Sumin, et al.
Published: (2018-04-01)

Multiplicity of comorbidities in patients with severe psoriasis
by: N. V. Batkaeva, et al.
Published: (2018-04-01)

Clinical Pharmacology of Vinpocetine: Properties Revisited and Introduction of a Population Pharmacokinetic Model for Its Metabolite, Apovincaminic Acid (AVA)
by: Zvonimir Petric, et al.
Published: (2023-10-01)

Inhibition of phosphodiesterase: A novel therapeutic target for the treatment of mild cognitive impairment and Alzheimer’s disease
by: Jianwen Sheng, et al.
Published: (2022-10-01)

Inhibition of PDE1-B by Vinpocetine Regulates Microglial Exosomes and Polarization Through Enhancing Autophagic Flux for Neuroprotection Against Ischemic Stroke
by: Jiankun Zang, et al.
Published: (2021-02-01)

Vinpocetine improves oxidative stress and pro-inflammatory mediators in acute kidney injury
by: Hayder M Al-Kuraishy, et al.
Published: (2019-01-01)